Literature DB >> 9861382

The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol).

M van Vugt1, F Ezzet, L Phaipun, F Nosten, N J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9861382     DOI： 10.1016/s0035-9203(98)90917-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  12 in total

1.  Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.

Authors:  Joel Tarning; Rose McGready; Niklas Lindegardh; Elizabeth A Ashley; Mupawjay Pimanpanarak; Benjamas Kamanikom; Anna Annerberg; Nicholas P J Day; Kasia Stepniewska; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

2.  Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.

Authors:  F Ezzet; M van Vugt; F Nosten; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

Authors:  N J White; M van Vugt; F Ezzet
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

4.  A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.

Authors:  Rose McGready; Saw Oo Tan; Elizabeth A Ashley; Mupawjay Pimanpanarak; Jacher Viladpai-Nguen; Lucy Phaiphun; Katja Wüstefeld; Marion Barends; Natthapon Laochan; Lily Keereecharoen; Niklas Lindegardh; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  PLoS Med       Date:  2008-12-23       Impact factor: 11.069

5.  HIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection.

Authors:  Ifeyinwa Chijioke-Nwauche; Albert van Wyk; Chijioke Nwauche; Khalid B Beshir; Harparkash Kaur; Colin J Sutherland
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

6.  Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.

Authors:  Sheelendra P Singh; Kanumuri S R Raju; Asad Nafis; Sunil K Puri; Girish K Jain
Journal:  Malar J       Date:  2011-10-10       Impact factor: 2.979

7.  In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia.

Authors:  Jimee Hwang; Bereket H Alemayehu; David Hoos; Zenebe Melaku; Samuel G Tekleyohannes; Takele Teshi; Sintayehu G Birhanu; Leykun Demeke; Kedir Gobena; Moges Kassa; Daddi Jima; Richard Reithinger; Henry Nettey; Michael Green; Joseph L Malone; S Patrick Kachur; Scott Filler
Journal:  Malar J       Date:  2011-07-28       Impact factor: 2.979

8.  Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.

Authors:  F Kloprogge; P Piola; M Dhorda; S Muwanga; E Turyakira; S Apinan; N Lindegårdh; F Nosten; N P J Day; N J White; P J Guerin; J Tarning
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-11-13

9.  Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.

Authors:  Myaing M Nyunt; Vy K Nguyen; Richard Kajubi; Liusheng Huang; Joshua Ssebuliba; Sylvia Kiconco; Moses W Mwima; Jane Achan; Francesca Aweeka; Sunil Parikh; Norah Mwebaza
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

10.  Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.

Authors:  Frank Kloprogge; Lesley Workman; Steffen Borrmann; Mamadou Tékété; Gilbert Lefèvre; Kamal Hamed; Patrice Piola; Johan Ursing; Poul Erik Kofoed; Andreas Mårtensson; Billy Ngasala; Anders Björkman; Michael Ashton; Sofia Friberg Hietala; Francesca Aweeka; Sunil Parikh; Leah Mwai; Timothy M E Davis; Harin Karunajeewa; Sam Salman; Francesco Checchi; Carole Fogg; Paul N Newton; Mayfong Mayxay; Philippe Deloron; Jean François Faucher; François Nosten; Elizabeth A Ashley; Rose McGready; Michele van Vugt; Stephane Proux; Ric N Price; Juntra Karbwang; Farkad Ezzet; Rajesh Bakshi; Kasia Stepniewska; Nicholas J White; Philippe J Guerin; Karen I Barnes; Joel Tarning
Journal:  PLoS Med       Date:  2018-06-12       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.